Qlaris Bio has reported positive topline outcomes from two Phase II US trials of QLS 111 in individuals with POAG and OHT.

Breast cancer is the most common cancer among women in the UK, with one in seven women being diagnosed with breast cancer in ...

Alys Pharmaceuticals has received clearance from the US FDA and Health Canada for a Phase IIa trial of ALY-101 for alopaecia ...

The Washington University trial comes as part of a larger platform study which hopes to understand if Alzheimer's disease can ...

The first-in-human SCS trial saw all three SMA patients able to increase their walking distance within six minutes to 20 meters.

RedHill Biopharma has begun a trial to assess the combination of opaganib and darolutamide for metastatic castrate-resistant ...

Cumberland Pharmaceuticals has reported positive outcomes from a trial of ifetroban as a potential treatment for Duchenne ...

On World Cancer Day, the UK Government has announced plans to launch a national trial to cut cancer screening wait times.

Makerere University, the Uganda Virus Research Institute and the WHO got the Uganda Ebola vaccine trial ready for dosing in ...

PhaseV has formed a strategic collaboration with Alimentiv for supporting the design and execution of adaptive clinical ...

Aplagon has secured a financing of €7m ($7.24m) to advance APAC, to primarily support the initiation of a Phase IIa trial for ...

In partnership with global institutions, IIT Guwahati researchers have developed an adaptive multi-stage trial method.